ArticleCureus2026
Fetal and Neonatal Complications Associated With Acute Fatty Liver of Pregnancy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Acute fatty liver of pregnancy (AFLP) is a rare but life-threatening obstetric emergency that can quickly endanger both the mother and fetus, typically presenting in the third trimester. Although greater awareness and supportive management have improved maternal survival, perinatal outcomes remain poor, particularly in resource-limited settings. This study aimed to describe fetal and neonatal complications associated with AFLP and identify maternal factors contributing to poor perinatal outcomes. Methods This retrospective study analysed medical records of 73 women diagnosed with AFLP at the Department of Obstetrics and Gynaecology, Unit I, Dr Ruth K. M. Pfau Civil Hospital Karachi, Dow University of Health Sciences, from November 3, 2024, to April 3, 2025. Diagnosis was based on the Swansea criteria. Maternal demographics, presenting symptoms, laboratory parameters, and neonatal outcomes were reviewed. Poor perinatal outcome was defined as stillbirth, early neonatal death, or a neonatal intensive care unit (NICU) stay exceeding seven days. Multivariate logistic regression was used to identify maternal predictors of adverse outcomes. Results The mean maternal age was 29 years, with most women presenting at an average gestational age of 35 weeks. Nausea and vomiting were reported in 64 (87.7%), malaise in 56 (76.7%), and jaundice in 47 (64.4%). Coagulopathy occurred in 31 (42.5%), while acute kidney injury was noted in 17 (23.3%). There were 13 stillbirths (17.8%) and five early neonatal deaths (6.8%), resulting in a perinatal mortality of 18 (24.6%). Lower gestational age, coagulopathy, and higher maternal bilirubin levels were independently associated with adverse perinatal outcomes. Conclusion Despite improvements in maternal management, perinatal mortality in AFLP remains alarmingly high. Early recognition and timely delivery, ideally before the onset of severe hepatic dysfunction, are critical for improving fetal survival. Strengthening neonatal intensive care facilities, developing national AFLP registries, and establishing standardised management protocols can play a key role in enhancing both maternal and neonatal outcomes in Pakistan and similar settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.